2024 Journal Article A multisociety Delphi consensus statement on new fatty liver disease nomenclatureRinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Narro, Graciela E. Castro, Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2024). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Annals of Hepatology, 29 (1) 101133. doi: 10.1016/j.aohep.2023.101133 |
2023 Journal Article A multisociety Delphi consensus statement on new fatty liver disease nomenclatureRinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Pablo Arab, Juan, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Castro Narro, Graciela E., Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78 (6), 1966-1986. doi: 10.1097/HEP.0000000000000520 |
2023 Journal Article Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsGracen, Lucy, Muthukumara, Withma, Aikebuse, Melanie, Russell, Anthony, O'Beirne, James, Irvine, Katharine M., Williams, Suzanne, Puri, Gaurav, Valery, Patricia C., Hayward, Kelly L. and Powell, Elizabeth E. (2023). Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists. Annals of Hepatology, 28 (6) 101142, 101142. doi: 10.1016/j.aohep.2023.101142 |
2023 Journal Article Gene variants implicated in steatotic liver disease: opportunities for diagnostics and therapeuticsHuang, Gary, Wallace, Daniel F., Powell, Elizabeth E., Rahman, Tony, Clark, Paul J. and Subramaniam, V. Nathan (2023). Gene variants implicated in steatotic liver disease: opportunities for diagnostics and therapeutics. Biomedicines, 11 (10) 2809, 1-15. doi: 10.3390/biomedicines11102809 |
2023 Journal Article Changing prevalence of medication use in people with cirrhosis: a retrospective cohort study using pharmaceutical benefits scheme dataHayward, Kelly L., Weersink, Rianne A., Bernardes, Christina M., McIvor, Carolyn, Rahman, Tony, Skoien, Richard, Clark, Paul J., Stuart, Katherine A., Hartel, Gunter, Valery, Patricia C. and Powell, Elizabeth E. (2023). Changing prevalence of medication use in people with cirrhosis: a retrospective cohort study using pharmaceutical benefits scheme data. Drugs - Real World Outcomes, 10 (4), 605-618. doi: 10.1007/s40801-023-00390-2 |
2023 Journal Article Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort studyO'Beirne, James, Skoien, Richard, Leggett, Barbara A., Hartel, Gunter F., Gordon, Louisa G., Powell, Elizabeth E. and Valery, Patricia C. (2023). Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study. Medical Journal of Australia, 219 (8), 358-365. doi: 10.5694/mja2.52104 |
2023 Journal Article A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levelsAllen, Michelle J, Doran, Rachael, Brain, David, Powell, Elizabeth E, O’Beirne, James, Valery, Patricia C, Barnett, Adrian, Hettiarachchi, Ruvini, Hickman, Ingrid J and Kularatna, Sanjeewa (2023). A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels. BMC Health Services Research, 23 (1) 950, 1-12. doi: 10.1186/s12913-023-09934-2 |
2023 Journal Article Predicting clinical outcomes in people with NAFLD: no need for a crystal ball?Valery, Patricia C. and Powell, Elizabeth E. (2023). Predicting clinical outcomes in people with NAFLD: no need for a crystal ball?. The Lancet Gastroenterology and Hepatology, 8 (8), 684-685. doi: 10.1016/s2468-1253(23)00149-8 |
2023 Journal Article Social networks and citizenship behavior: the mediating effect of organizational identificationZagenczyk, Thomas J. and Powell, E. Erin (2023). Social networks and citizenship behavior: the mediating effect of organizational identification. Human Resource Management, 62 (4), 461-475. doi: 10.1002/hrm.22144 |
2023 Journal Article Differences in the pattern and cost of hospital care between Indigenous and non‐Indigenous Australians with cirrhosis: an exploratory studyAmarasena, Samath, Clark, Paul J., Gordon, Louisa G., Toombs, Maree, Pratt, Greg, Hartel, Gunter, Bernardes, Christina M., Powell, Elizabeth E. and Valery, Patricia C. (2023). Differences in the pattern and cost of hospital care between Indigenous and non‐Indigenous Australians with cirrhosis: an exploratory study. Internal Medicine Journal, 53 (6), 961-969. doi: 10.1111/imj.15854 |
2023 Journal Article Low prevalence of use of allied health and community services for patients with cirrhosis in Australia: a need for greater engagementPowell, Elizabeth E., Stuart, Katherine A., Finnigan, Simon, Hinson, Jan, Bernardes, Christina M., Hartel, Gunter and Valery, Patricia C. (2023). Low prevalence of use of allied health and community services for patients with cirrhosis in Australia: a need for greater engagement. Patient Preference and Adherence, 17, 1117-1130. doi: 10.2147/ppa.s405567 |
2023 Journal Article Higher levels of supportive care needs are linked to higher health service use and cost, poor quality of life, and high distress in patients with cirrhosis in Queensland, AustraliaValery, Patricia C., Stuart, Katherine A., Bernardes, Christina M., Hartel, Gunter, Martin, Cathy, Gordon, Louisa and Powell, Elizabeth E. (2023). Higher levels of supportive care needs are linked to higher health service use and cost, poor quality of life, and high distress in patients with cirrhosis in Queensland, Australia. Hepatology Communications, 7 (3) e0066, 1-13. doi: 10.1097/hc9.0000000000000066 |
2023 Journal Article A multisociety Delphi consensus statement on new fatty liver disease nomenclatureRinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Castro Narro, Graciela E., Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Journal of Hepatology, 79 (6), 1542-1556. doi: 10.1016/j.jhep.2023.06.003 |
2023 Journal Article Serum CCL2 is associated with visceral adiposity but not fibrosis in patients with Non-alcoholic Fatty Liver Disease (NAFLD)Ferrari-Cestari, Michelle, Okano, Satomi, Patel, Preya J., Horsfall, Leigh U., Keshvari, Sahar, Hume, David A., Williams, Suzanne, Russell, Anthony, Powell, Elizabeth E. and Irvine, Katharine M (2023). Serum CCL2 is associated with visceral adiposity but not fibrosis in patients with Non-alcoholic Fatty Liver Disease (NAFLD). Digestive Diseases, 41 (3), 439-446. doi: 10.1159/000527784 |
2022 Journal Article Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetesGracen, Lucy, Hayward, Kelly L., Aikebuse, Melanie, Russell, Anthony, O’Beirne, James, McPhail, Steven, Irvine, Katharine M., Williams, Suzanne, Valery, Patricia C. and Powell, Elizabeth E. (2022). Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes. BMC Health Services Research, 22 (1) 487, 1-11. doi: 10.1186/s12913-022-07808-7 |
2022 Journal Article Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory studyValery, Patricia C., Bernardes, Christina M., Hayward, Kelly L., Hartel, Gunter, Haynes, Katelin, Gordon, Louisa G., Stuart, Katherine A., Wright, Penny L., Johnson, Amy and Powell, Elizabeth E. (2022). Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study. BMC Gastroenterology, 22 (1) 340, 1-11. doi: 10.1186/s12876-022-02407-6 |
2022 Journal Article Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLDCanivet, Clémence M., Costentin, Charlotte, Irvine, Katharina M., Delamarre, Adèle, Lannes, Adrien, Sturm, Nathalie, Oberti, Frederic, Patel, Preya J., Decaens, Thomas, Irles-Depé, Marie, Fouchard, Isabelle, Hermabessière, Paul, Roux, Marine, Barthelon, Justine, Calès, Paul, Powell, Elizabeth E., de Ledinghen, Victor and Boursier, Jérôme (2022). Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD. Hepatology, 77 (3), n/a-n/a. doi: 10.1002/hep.32665 |
2022 Journal Article Low accuracy of FIB-4 test to identify people with diabetes at low risk of advanced fibrosisGracen, Lucy, Hayward, Kelly L., Irvine, Katharine M., Valery, Patricia C. and Powell, Elizabeth E. (2022). Low accuracy of FIB-4 test to identify people with diabetes at low risk of advanced fibrosis. Journal of Hepatology, 77 (4), 1219-1221. doi: 10.1016/j.jhep.2022.06.016 |
2022 Journal Article Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: a population-based studyRatnasekera, Isanka U., Johnson, Amy, Powell, Elizabeth E., Henderson, Andrew, Irvine, Katharine M. and Valery, Patricia C. (2022). Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: a population-based study. Medicine, 101 (20) 00010, e29217. doi: 10.1097/MD.0000000000029217 |
2022 Journal Article Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosisHayward, Kelly L., Bansal, Vikas, Valery, Patricia C., Irvine, Katharine M., Wright, Penny L., Tallis, Caroline J., Stuart, Katherine A., Cottrell, W. Neil, Martin, Jennifer H. and Powell, Elizabeth E. (2022). Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis. Hepatology Communications, 6 (11), 3281-3282. doi: 10.1002/hep4.1999 |